| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Cardiovascular Medicine, University of California, Davis, California 95616; and 2 Division of Cardiology, Columbia University, New York, New York 10032
Alterations in glucose metabolism have been implicated in the cardiovascular complications of diabetes. Previous work in this laboratory demonstrated that hearts from diabetic animals have an elevated cytosolic redox ratio (NADH/NAD+) and that this redox imbalance is probably due to elevated polyol pathway flux. We therefore hypothesized that 1) the elevated cytosolic redox ratio of diabetic hearts could result in inhibition of glycolytic enzymes sensitive to the redox state, 2) polyol pathway inhibition could restore the abnormal glucose metabolism of diabetic hearts, and 3) the relative incorporation of mixed substrates into hearts from diabetic animals would demonstrate less glycolytic and more fatty acid oxidation. Hearts from diabetic (BB/W) and nondiabetic control rats were perfused with buffers containing 13C-labeled substrates, and the metabolism of these hearts was analyzed using 13C NMR spectroscopy. Tissue samples were analyzed for metabolite levels using biochemical assay. Compared with controls, diabetic hearts had glyceraldeyde 3-phosphate levels that were four times greater than nondiabetic hearts and exhibited 91% less 13C labeling of lactate and 92% less 13C labeling of glutamate (P < 0.03). Aldose reductase inhibition with zopolrestat restored the metabolite labeling of diabetic hearts. Diabetic hearts perfused with a mixture of substrates used 53% more acetate than nondiabetic control hearts (P < 0.05), and aldose reductase inhibition lowered the acetate utilization of diabetic hearts by 9% (P < 0.05). These data suggest that glycolytic flux in diabetic hearts is inhibited at glyceraldehyde-3-phosphate dehydrogenase and that inhibition of the polyol pathway with zopolrestat increases glycolytic flux in these hearts. Furthermore, hearts from diabetic animals showed a marked dependence on fatty acids for substrate utilization compared with nondiabetic controls, consistent with inhibition of the pyruvate dehydrogenase complex in diabetic hearts.
carbon-13 nuclear magnetic resonance; NADH/NAD+; glyceraldehyde 3-phosphate dehydrogenase
This article has been cited by other articles:
|
|
 |
|
  J. C. Chatham, C. Des Rosiers, and J. R. Forder Evidence of separate pathways for lactate uptake and release by the perfused rat heart Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E794 - E802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Tracey, W. P. Magee, C. A. Ellery, J. T. MacAndrew, A. H. Smith, D. R. Knight, and P. J. Oates Aldose reductase inhibition alone or combined with an adenosine A3 agonist reduces ischemic myocardial injury Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1447 - H1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Trueblood, R. Ramasamy, L. F. Wang, and S. Schaefer Niacin protects the isolated heart from ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H764 - H771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ramasamy, N. Trueblood, and S. Schaefer Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H195 - H203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Du Yan, Y. Zhu, E. D. Stern, Y. C. Hwang, O. Hori, S. Ogawa, M. P. Frosch, E. S. Connolly Jr., R. McTaggert, D. J. Pinsky, et al. Amyloid beta -Peptide-binding Alcohol Dehydrogenase Is a Component of the Cellular Response to Nutritional Stress J. Biol. Chem., August 25, 2000; 275(35): 27100 - 27109. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
